Patrick Y Yang insider trades: Sana Biotechnology (SANA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Patrick reports to the SEC
and 1 more company
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | SANA | ↓ Sell | 25,000 | $9.45 | $236K | Direct | Mar 11, 2024 (3d) |
| Mar 21, 2022 | SANA | ↑ Buy | 28,000 | $7.30 | $204K | Direct | Mar 22, 2022 (1d) |
| Mar 15, 2022 | CDXS | ↓ Sell | 8,000 | $16.79 | $134K | Direct | Mar 16, 2022 (1d) |
| Dec 13, 2021 | CDXS | ↓ Sell | 8,000 | $31.60 | $253K | Direct | Dec 14, 2021 (1d) |
| Jun 16, 2021 | CDXS | ↓ Sell | 20,000 | $20.31 | $406K | Direct | Jun 17, 2021 (1d) |
| Apr 6, 2021 | CDXS | ↓ Sell | 20,000 | $24.71 | $494K | Direct | Apr 7, 2021 (1d) |
| Dec 10, 2019 | AMRS | ↓ Sell | 10,671 | $3.10 | $33K | Direct | Dec 12, 2019 (2d) |
| Sep 6, 2019 | CDXS | ↑ Buy | 8,000 | $13.69 | $110K | Direct | Sep 6, 2019 (0d) |
| Sep 3, 2019 | CDXS | ↑ Buy | 6,000 | $13.97 | $84K | Direct | Sep 4, 2019 (1d) |
| Aug 22, 2019 | CDXS | ↑ Buy | 12,000 | $12.94 | $155K | Direct | Aug 26, 2019 (4d) |
| Dec 20, 2018 | CDXS | ↓ Sell | 50,000 | $18.52 | $926K | Direct | Dec 21, 2018 (1d) |
| Sep 19, 2018 | CDXS | ↓ Sell | 50,000 | $18.20 | $910K | Direct | Sep 20, 2018 (1d) |
| Aug 16, 2018 | CDXS | ↓ Sell | 150,340 | $14.45 | $2.2M | By Patrick & Shu-O Yang TTEES | Aug 20, 2018 (4d) |
| Aug 13, 2018 | AMRS | ↑ Buy | 15,000 | $7.66 | $115K | Direct | Aug 15, 2018 (2d) |
| Aug 9, 2018 | AMRS | ↑ Buy | 10,000 | $7.71 | $77K | Direct | Aug 13, 2018 (4d) |
| Jul 19, 2018 | CDXS | ↓ Sell | 50,000 | $15.46 | $773K | Direct | Jul 20, 2018 (1d) |
| May 19, 2017 | AMRS | ↑ Buy | 300,000 | $0.29 | $87K | Direct | May 22, 2017 (3d) |
| Nov 15, 2016 | CDXS | ↑ Buy | 10,000 | $4.83 | $48K | Direct | Nov 15, 2016 (0d) |
| Sep 11, 2015 | CDXS | ↑ Buy | 10,000 | $3.47 | $35K | Direct | Sep 15, 2015 (4d) |
| Aug 24, 2015 | CDXS | ↑ Buy | 10,000 | $3.84 | $38K | Direct | Aug 25, 2015 (1d) |
| Aug 21, 2015 | CDXS | ↑ Buy | 10,000 | $3.98 | $40K | Direct | Dec 7, 2017 (839d) |
| Aug 14, 2015 | CDXS | ↑ Buy | 20,000 | $3.97 | $79K | Direct | Aug 17, 2015 (3d) |
| May 14, 2015 | TSO | ↓ Sell | 10,000 | $92.01 | $920K | Direct | May 14, 2015 (0d) |
| Nov 18, 2014 | CDXS | ↑ Buy | 20,000 | $2.35 | $47K | Direct | Nov 20, 2014 (2d) |
| Nov 17, 2014 | CDXS | ↑ Buy | 20,000 | $2.34 | $47K | Direct | Nov 19, 2014 (2d) |
| Aug 12, 2014 | CDXS | ↑ Buy | 60,000 | $2.22 | $133K | Direct | Aug 14, 2014 (2d) |
| Aug 13, 2013 | TSO | ↑ Buy | 4,000 | $51.85 | $207K | Direct | Aug 14, 2013 (1d) |
| Aug 13, 2013 | TSO | ↑ Buy | 4,000 | $51.85 | $207K | Direct | Aug 14, 2013 (1d) |
| Aug 12, 2011 | TSO | ↑ Buy | 3,000 | $20.15 | $60K | Direct | Aug 12, 2011 (0d) |
| Jul 21, 2008 | DNA | ↓ Sell | 50,000 | $92.98 | $4.6M | Direct | Jul 23, 2008 (2d) |
| May 31, 2005 | DNA | ↓ Sell | 35,000 | $79.75 | $2.8M | Direct | Jun 2, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Patrick Y Yang's insider trades
Patrick Y Yang is an insider at Sana Biotechnology (SANA). Since May 31, 2005, Patrick has reported 18 open-market purchases worth $1.8M and 13 sales worth $14.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (55 filings), shares returned to the company (5 filings), option exercises (5 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SANA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.